Introduction Extractables and Leachables (E&L) Requirements for Single-Use Bioprocessing in cell therapy programs define the analytical frameworks and risk assessment […]
Introduction Liquid chromatography-tandem mass spectrometry (LC-MS/MS) offers the sensitivity, mass accuracy, and structural resolution necessary for detecting, localizing, and quantifying
Introduction The fundamental Difference Between Biosimilar and Biologic Manufacturing from a quality perspective is rooted in the primary objective of
Introduction: PLGA Inhalable Microparticle Development combines polymer science, particle engineering, analytical characterization, and inhalation-product performance testing to create a formulation
Introduction Reference Listed Drug (RLD) Sourcing and Reverse Engineering provide the essential scientific and regulatory foundation for Abbreviated New Drug
Reference Listed Drug (RLD) Sourcing and Reverse Engineering: The CDMO’s Role in ANDA Read More »
Introduction The use of Peptide-Oligonucleotide Conjugate (POCs) in CNS Drug Delivery represents an advanced bioconjugation strategy designed to transport therapeutic
Introduction Preparing a Full Characterization Data Package for a GLP-1 Receptor Agonist ANDA is a critical regulatory milestone for demonstrating
Introduction NDSRI Quantification at Ultra-Low Levels requires advanced liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodologies capable of detecting mutagenic impurities at
Introduction Selecting between Spray Drying vs Solvent Evaporation for poly(lactic-co-glycolic acid) (PLGA) microsphere fabrication requires careful consideration of processing throughput,
Introduction Comprehensive GLP-1 Receptor Agonist Characterization Services for ANDA submissions generate the critical physicochemical, structural, and biological evidence necessary to
